Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168592 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Giuseppe Gigliotti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department Nephrology and Dialysis, Eboli Hospital, 84025 Eboli, Italy. Hauptthemen laut MEDLINE: Precision Medicine, Epigenesis, Genetic, Gastrointestinal Microbiome, Kidney Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Personalized medicine, which involves modifying treatment strategies/drug dosages based on massive laboratory/imaging data, faces large statistical and study design problems. The authors believe that the use of continuous multidimensional data, such as those regarding gut microbiota, or binary multidimensional systems properly transformed into a continuous variable, such as the epigenetic clock, offer an advantageous scenario for the design of trials of personalized medicine. We will discuss examples focusing on kidney diseases, specifically on IgA nephropathy. While gut dysbiosis can provide a treatment strategy to restore the standard gut microbiota using probiotics, transforming epigenetic omics data into epigenetic clocks offers a promising tool for personalized acute and chronic kidney disease care. Epigenetic clocks involve a complex transformation of DNA methylome data into estimated biological age. These clocks can identify people at high risk of developing kidney problems even before symptoms appear. Some of the effects of both the epigenetic clock and microbiota on kidney diseases seem to be mediated by endothelial dysfunction. These “big data” (epigenetic clocks and microbiota) can help tailor treatment plans by pinpointing patients likely to experience rapid declines or those who might not need overly aggressive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department Nephrology and Dialysis, Eboli Hospital, 84025 Eboli, Italy.
- Department Translational Medical Sciences, University of Campania, 81100 Naples, Italy.
- Vidmar-Daj Consulting, New York, NY 07093, USA.
- Department Experimental Medicine, University of Campania, 81100 Naples, Italy.
- Department Life Sciences, Health and Health Professions, Link University, 00165 Rome, Italy.
ORCID-Profile: Rashmi Joshi, Mariarosaria Boccellino, Davide Viggiano
Zitieren
APA
Gigliotti, G., Joshi, R., Khalid, A., Widmer, D., Boccellino, M., & Viggiano, D. (2024). Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168592
Vancouver
Gigliotti G, Joshi R, Khalid A, Widmer D, Boccellino M, Viggiano D. Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168592
BibTeX
@article{Gigliotti2024,
author = {Gigliotti, Giuseppe and Joshi, Rashmi and Khalid, Anam and Widmer, David and Boccellino, Mariarosaria and Viggiano, Davide},
title = {Epigenetics, Microbiome and Personalized Medicine: Focus on Kidney Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168592}
}
EUVIMED